Aruna Bio Revenue and Competitors

Athens-Clarke, GA USA

Location

#7657

Growjo Ranking

Research

Industry

Estimated Revenue & Valuation

  • Aruna Bio's estimated annual revenue is currently $2.9M per year.(i)
  • Aruna Bio's estimated revenue per employee is $65,461
  • Aruna Bio's total funding is $33M.

Employee Data

  • Aruna Bio has 45 Employees.(i)
  • Aruna Bio grew their employee count by 7% last year.

Aruna Bio's People

NameTitleEmail/Phone
1
Director, Nonclinical ResearchReveal Email/Phone
2
Director QualityReveal Email/Phone
3
Research Scientist, DiscoveryReveal Email/Phone
4
Research AssociateReveal Email/Phone
5
Research associate IIReveal Email/Phone
6
Analytical Development ScientistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1.1M18-18%N/AN/A
#2
$3.5M4313%N/AN/A
#3
$3.2M390%N/AN/A
#4
$3.5M43N/AN/AN/A
#5
$3.6M445%N/AN/A
#6
$2M288%N/AN/A
#7
$22.8M2032%N/AN/A
#8
$0.2M4N/AN/AN/A
#9
$3.1M389%N/AN/A
#10
$1M17-11%N/AN/A
Add Company

What Is Aruna Bio?

Aruna Bio was the first to commercialize human neural stem cells derived from human pluripotent stem cells. For over twelve years, we manufactured and provided neural stem cells to the world’s leading research organizations with unrivaled uniformity and scale. Today, we are advancing a new class of cell-free biologics, exosomes, for the treatment of neurodegenerative disorders and leveraging our novel platform to optimize the delivery of RNAs, antibodies, genes and small molecules for our partners.

keywords:N/A

$33M

Total Funding

45

Number of Employees

$2.9M

Revenue (est)

7%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Aruna Bio News

2022-04-19 - Form PRE 14A 9 METERS BIOPHARMA, INC. For: Apr 22

In January 2019, Dr. Sirgo was appointed Chief Executive Officer of Aruna Bio, Inc., a private development-stage company focused on central...

2021-04-14 - Aruna Bio Closes $10.8 Million Common Stock Financing

ATHENS, Ga. and RESEARCH TRIANGLE PARK, N.C., April 14, 2021 (GLOBE NEWSWIRE) -- Aruna Bio, Inc., a leader in the development of neural exosomes for the treatment of neurodegenerative diseases, today announced the closing of a common stock financing totaling $10.8 million. Proceeds from the rais ...

2019-07-29 - Athens Biotech Firm Treating ALS, Strokes Raises $13M

ArunA Bio, a biotech company based in Athens, has raised $13 million from Eshelman Ventures, members of the company’s board of directors and management, and other investors. ArunA Bio will use the funding to support the development of its neural exosome delivery platform and neural exosome ther ...

2019-07-24 - ArunA Bio Raises $13M in Common Stock Financing

ArunA Bio, Inc., an Athens, Ga.-based leader in the development of neural exosomes for the treatment of neurodegenerative diseases, completed a $13m common stock financing. The financing included both existing and new private investors along with participation by several institutional investors ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$7.5M69-1%N/A
#2
$26.7M815%N/A
#3
$23M85-13%N/A
#4
$20.2M961%N/A
#5
$29.3M1015%N/A